securities fraud

Ultragenyx faces class action lawsuit for allegedly misleading investors about setrusumab efficacy and failing to disclose Phase III trial risks adequately.

Class action lawsuits filed against Ultragenyx and Mereo after Phase III clinical trials for setrusumab failed. Stock prices plummeted 42% and 88% respectively following the announcement.

Class action lawsuits filed against BlackRock TCP Capital and Plug Power for alleged material misrepresentations regarding financial information and business operations.

PayPal faces class action lawsuit alleging misleading revenue guidance. Stock dropped 20% after weak Q4 results and withdrawn 2027 guidance; CEO transition announced.

KDDI delayed earnings disclosure due to internal investigation, triggering 11.44% stock decline. Law firm investigating potential securities law violations.

Kyndryl faces securities fraud lawsuit over alleged misrepresentations. Stock plunged 55% after February disclosure of internal control weaknesses. Investors have until April 13 to join class action.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and supplier risks. March 13, 2026 deadline set for investors to claim lead plaintiff status.

uniQure stock plummeted 49% after FDA rejected accelerated approval for gene therapy AMT-130, triggering a class action lawsuit alleging securities fraud.

BellRing Brands faces securities fraud lawsuit for allegedly failing to disclose significant inventory issues. Stock fell 52% during the class period amid operational challenges.

Class action lawsuit filed against PayPal for allegedly making false statements about 2027 financial targets and Branded Checkout expansion while concealing sales organization problems.

Law firm investigates Beta Bionics for potential securities fraud after stock plunged 37% due to slowing patient growth, missing investor expectations on guidance accuracy.

Law firm investigates Ashford Hospitality Trust for potential securities violations following dividend suspension and mortgage disclosure. Stock fell 8.1%.

Law firm Pomerantz LLP investigates First Western Financial for potential securities violations following earnings miss and 8.81% stock drop on January 23, 2026.

Law firm investigates Celestica for potential securities fraud after reports Google may shift TPU assembly work to other suppliers, raising disclosure concerns.

Pomerantz investigates First Citizens BancShares for potential securities fraud following disappointing Q4 earnings and weak guidance, triggering an 8.49% stock decline.

Pomerantz launches class action against Vistagen after failed clinical trial caused 80% stock drop. March 16, 2026 deadline for investors to join lawsuit.

Class action lawsuit filed against China Liberal Education for alleged securities fraud involving fraudulent social media advisors that artificially inflated stock prices before collapse.

Oracle faces securities lawsuit for allegedly misrepresenting AI infrastructure investment returns and failing to disclose significant financial obligations and project delays.

Law firm Block & Leviton investigates GEMI for potential securities violations after three senior executives departed amid 10% stock decline and 25% workforce reduction.

Portnoy Law Firm files class action against Oracle for failing to timely disclose a $15 billion CapEx increase tied to its OpenAI partnership deal.